PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Using 4D printing to enable vascularization, bone tissue regeneration, spinal fusion

4D printing helps create a biomimetic microchannel scaffold made of collagen and hydroxyapatite.

Using 4D printing to enable vascularization, bone tissue regeneration, spinal fusion
2021-05-04
(Press-News.org) WASHINGTON, May 4, 2021 -- Spinal fusion is frequently performed to restore spinal stability in patients with spinal diseases, such as spinal stenosis, vertebral fractures, progressive deformities, and instability. In the past two decades, there has been marked increase in the number of people over 65 years in age who have needed spinal fusion surgery.

While autogenous bone grafts have long been considered the reference standard for spinal fusion, painful pseudoarthrosis remains a leading cause of poor clinical outcomes. Many researchers have consequently focused on trying to create a biomimetic scaffold that induces vascularization to enable bone tissue regeneration and spinal fusion.

In Applied Physics Reviews, from AIP Publishing, researchers from Sungkyunkwan University in South Korea present a solution to address the challenge of fabrication of a biomimetic scaffold. The team designed a microchannel scaffold made of a collagen and hydroxyapitite combination, with each strut consisting of micrometer-scaled microchannels. The microchannels have induced growth of blood vessels in a mouse model.

"Since the fabrication of biomimetic scaffold is a challenging issue, the innovation of this study lies in adding extra hierarchy to the structure in the form of microchannels," said author Geun Hyung Kim. "This was achieved through a 4D printing strategy, where one-way shape morphing is used."

The researchers printed immiscible polymer blends that act as a double negative template in order to fabricate the the biomimetic collagen/hydroxyapatite hierarchical scaffold. They followed that by one-way shape morphing (4D printing) and coating processes.

Collagen is known as a hydrophilic material, and numerous in vivo studies have suggested it possesses excellent cellular activities. In the case of the microchanneled collagen/hydroxyapatite scaffold, the researchers noted significantly higher water-absorbing capability, compared to a conventional collagen scaffold, as a result of the capillary pressure supplied by the microchannels. Consequently, the in vivo studies have suggested excellent infiltration of cells into microchannels.

Going forward, the researchers will investigate enhancing the mechanical properties of the scaffold. Furthermore, controlling the mechanical properties of the scaffold would enable versatile applications of the microchanneled collagen/hydroxyapatite scaffold.

"I believe that the designed scaffold can have multiple applications with tubular structures such as muscle, tendon, and nerve," said Kim.

Skeletal muscle is a hierarchical organization where the muscle fibers are encapsulated in microchannels known as endomysium. Therefore, the designed scaffold could act as endomysium to enable the infiltration of muscle fibers into the channels.

INFORMATION:

The article "Bone tissue engineering via application of a collagen/hydroxyapatite 4D-printed biomimetic scaffold for spinal fusion" is authored by Hanjun Hwangbo, Hyeongjin Lee, Eun Ji Roh, WonJin Kim, Hari Prasad Joshi, Su Yeon Kwon, Un Yong Choi, In-Bo Han, and Geun Hyung Kim. The article will appear in Applied Physics Reviews on May 4, 2021 (DOI: 10.1063/5.0035601). After that date, it can be accessed at https://aip.scitation.org/doi/10.1063/5.0035601.

ABOUT THE JOURNAL

Applied Physics Reviews features articles on significant and current topics in experimental or theoretical research in applied physics, or in applications of physics to other branches of science and engineering. The journal publishes both original research on pioneering studies of broad interest to the applied physics community, and reviews on established or emerging areas of applied physics. See https://aip.scitation.org/journal/are.


[Attachments] See images for this press release:
Using 4D printing to enable vascularization, bone tissue regeneration, spinal fusion

ELSE PRESS RELEASES FROM THIS DATE:

Cellphone converts into powerful chemical detector

Cellphone converts into powerful chemical detector
2021-05-04
WASHINGTON, May 4, 2021 -- Scientists from Texas A&M have developed an extension to an ordinary cellphone that turns it into an instrument capable of detecting chemicals, drugs, biological molecules, and pathogens. The advance is reported in Reviews of Scientific Instruments, by AIP Publishing. Modern cellphones include high-quality cameras capable of detecting low levels of light and eliminating digital noise through software processing of the captured images. Recent work has taken advantage of this sensitivity to produce cellphone cameras that ...

Surgery to prevent breast cancer requires a patient-doctor dialogue about risks, benefits

2021-05-04
SAN ANTONIO (May 4, 2021) - Risk-reducing mastectomy saves lives of women who, because of hereditary or other risk factors, may have a very high lifetime risk of developing breast cancer, according to two new journal articles written to guide physicians and patients. All of these women should also discuss with their physicians nonsurgical options such as screening and medications to reach the best, customized treatment strategy, the essays mention. Both articles, published May 4 in the Journal of the American Medical Association (JAMA), are by END ...

Original investigation: When drug companies raise list prices, out-of-pocket costs for patients

2021-05-04
WHO Benjamin Rome, MD, Instructor of Medicine at Harvard Medical School and researcher in the Program On Regulation, Therapeutics, And Law (PORTAL) in the Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital; corresponding author of a paper published in JAMA Network Open. WHAT When drug manufacturers raise the list price for brand-name prescription drugs, do patients' out-of-pocket costs rise too? A new study published in JAMA Network Open by Dr. Benjamin Rome and colleagues in the Brigham's Division of Pharmacoepidemiology and Pharmacoeconomics finds that more than half of patients may experience increases in out-of-pocket spending when drug ...

Team cracks century-old mystery over the health struggles of explorer Ernest Shackleton

2021-05-04
BOSTON - Researchers from Massachusetts General Hospital (MGH) appear to have solved the 120-year-old mystery surrounding the failing health of famed Antarctic explorer Sir Ernest Shackleton over the course of his daring expeditions to Antarctica in the early part of the twentieth century. In a paper published online in the END ...

Do people aged 105 and over live longer because they have more efficient DNA repair?

2021-05-04
Researchers have found that people who live beyond 105 years tend to have a unique genetic background that makes their bodies more efficient at repairing DNA, according to a study published today in eLife. This is the first time that people with 'extreme longevity' have had their genomes decoded in such detail, providing clues as to why they live so long and manage to avoid age-related diseases. "Aging is a common risk factor for several chronic diseases and conditions," explains Paolo Garagnani, Associate Professor at the Department of Experimental, Diagnostic ...

Changes in proteins play important role in aging kidneys

2021-05-04
Studying protein changes in the kidneys as we age, as well as the transcription of genes into proteins, helps provide a full picture of the age-related processes that take place in these organs, says a study in mice published today in eLife. Aging causes many changes in the body and in essential organs such as the kidneys, which function less efficiently later in life. Age-related changes in the kidneys have mostly been reported by looking at the transcription of genes - the process by which a segment of DNA is copied into RNA. The current study suggests that this approach, combined with studying changes in proteins, gives us a better understanding of age-related changes in the kidney and may point to new approaches for treating ...

New neuroimaging technique studies brain stimulation for depression

New neuroimaging technique studies brain stimulation for depression
2021-05-04
TAMPA, Fla. (May 4, 2021) -- Repetitive transcranial magnetic stimulation, or rTMS, was FDA approved in 2008 as a safe and effective noninvasive treatment for severe depression resistant to antidepressant medications. A small coil positioned near the scalp generates repetitive, pulsed magnetic waves that pass through the skull and stimulate brain cells to relieve symptoms of depression. The procedure has few side effects and is typically prescribed as an alternative or supplemental therapy when multiple antidepressant medications and/or psychotherapy do not work. Despite increased use ...

Population-based study shows air pollution exposure contributes to childhood asthma

2021-05-04
LONDON, ON - New findings from Ontario have shown that children born in Sarnia have a higher risk of developing asthma compared to neighbouring cities. A research team from Lawson Health Research Institute and Western University, using provincial data from ICES, found that higher air pollution exposure in the first year of life very likely contributed to this higher risk. Their results are published today in CMAJ Open. Summary of study results: -Children born in Sarnia in the 1990s and early 2000s were disproportionally at a higher risk of developing asthma in the first few years of life, compared to neighbouring cities. -Air pollution exposure ...

Forest fires drive expansion of savannas in the heart of the Amazon

Forest fires drive expansion of savannas in the heart of the Amazon
2021-05-04
Agência FAPESP – White-sand savannas are expanding in the heart of the Amazon as a result of recurring forest fires, according to a study published in the journal Ecosystems. The study was supported by FAPESP, and conducted by Bernardo Monteiro Flores, currently a postdoctoral fellow in ecology at the Federal University of Santa Catarina (UFSC) in Brazil, and Milena Holmgren, a professor in the Department of Environmental Sciences at Wageningen University in the Netherlands. “The edges of the Amazon Rainforest have long been considered the ...

Researchers identify potential combination therapy for aggressive lung cancer

2021-05-04
FINDINGS A new study by researchers at the UCLA Jonsson Comprehensive Cancer Center has identified a novel combination therapy to potentially help overcome resistance to immunotherapy in people diagnosed with advanced lung cancer. The combination approach uses immune checkpoint inhibitors with ATRA, a safe medication that is widely used to treat leukemia. The team found the combination therapy led to eradication of over 70% of tumors when tested in mice with LKB1-deficient lung cancer. It also generated durable tumor-specific immunity. BACKGROUND Immune checkpoint inhibitors have substantially ...

LAST 30 PRESS RELEASES:

First-in-human trial shows promising results for DLL3-targeted antibody-drug conjugate SHR-4849 in relapsed small cell lung cancer

Ifinatamab deruxtecan demonstrates high response rate in previously treated extensive-stage small cell lung cancer: Phase 2 IDeate-Lung01 trial

Higher blood pressure in childhood linked to earlier death from heart disease in adulthood

AI helped older adults report accurate blood pressure readings at home

High blood pressure in childhood and premature cardiovascular disease mortality

Zidesamtinib shows durable responses in ROS1 TKI pre-treated NSCLC, including patients with CNS disease and ROS1 G2032R mutations

Crizotinib fails to improve disease-free survival in resected early-stage ALK+ NSCLC

Ivonescimab plus chemotherapy improves progression-free survival in patients with EGFR+ NSCLC following 3rd-generation EGFR-TKI therapy

FLAURA2 trial shows osimertinib plus chemotherapy improves overall survival in eGFR-mutated advanced NSCLC

Aumolertinib plus chemotherapy improves progression-free survival in NSCLC with EGFR and concomitant tumor suppressor genes: ACROSS 2 phase III study

New antibody-drug conjugate shows promising efficacy in EGFR-mutated NSCLC patients

Iza-Bren in combination with osimertinib shows 100% response rate in EGFR-mutated NSCLC, phase II study finds

COMPEL study shows continuing osimertinib treatment through progression with the addition of chemotherapy improves progression-free survival in EGFR-mutated NSCLC

CheckMate 77T: Nivolumab maintains quality of life and reduces symptom deterioration in resectable NSCLC

Study validates AI lung cancer risk model Sybil in predominantly Black population at urban safety-net hospital

New medication lowered hard-to-control high blood pressure in people with chronic kidney disease

Innovative oncolytic virus and immunotherapy combinations pave the way for advanced cancer treatment

New insights into energy metabolism and immune dynamics could transform head and neck cancer treatment

Pennington Biomedical’s Dr. Steven Heymsfield named LSU Boyd Professor – LSU’s highest faculty honor

Study prompts new theory of human-machine communication

New method calculates rate of gene expression to understand cell fate

Researchers quantify rate of essential evolutionary process in the ocean

Innovation Crossroads companies join forces, awarded U.S. Air Force contract

Using new blood biomarkers, USC researchers find Alzheimer’s disease trial eligibility differs among various populations

Pioneering advances in in vivo CAR T cell production

Natural medicines target tumor vascular microenvironment to inhibit cancer growth

Coral-inspired pill offers a new window into the hidden world of the gut

nTIDE September2025 Jobs Report: Employment for people with disabilities surpasses prior high

When getting a job makes you go hungry

Good vibrations could revolutionize assisted reproductive technology

[Press-News.org] Using 4D printing to enable vascularization, bone tissue regeneration, spinal fusion
4D printing helps create a biomimetic microchannel scaffold made of collagen and hydroxyapatite.